Learning Center
Vesicants: New Evidence and Risk Prevention
-
Register
- Non-member - $325
- Member - $245
An INS task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the extravasation prevention checklist. Presented by members of the task force, this INS virtual symposium addresses 5 challenging aspects of mitigating the risk of extravasations: identifying vesicants, optimal vascular access device and site choice, clinical practices to avoid extravasation, prevention of legalities with case study examples, and implementation of organizational policies and procedures. Extravasation may result in severe patient injuries including scarring, permanent functional impairment, and even loss of a limb. Such injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. At the conclusion of the meeting, you will be able to claim 5 contact hours and 10 CRNI® recertification units.
-
Contains 1 Component(s)
Please complete the meeting evaluation to receive your continuing education certificate. Your feedback is important, as it helps INS better serve you and the membership. We need your input to continue to provide you with quality programs.
Please complete the meeting evaluation to receive your continuing education certificate. Your feedback is important, as it helps INS better serve you and the membership. We need your input to continue to provide you with quality programs.
-
Contains 1 Component(s)
Q&A
Q&A
Ruth Van Gerpen, MS, RN, APRN-CNS, AOCNS, PGMT-BC
Ruth Van Gerpen, MS, RN, APRN-CNS, AOCNS, PGMT-BC, is a clinical nurse specialist for oncology in Lincoln, Nebraska. An RN for 45 years, she has over 37 years of experience in oncology with subspecialties in pain management and vascular access. She retired in January 2022. Ruth has been responsible for education related to cancer; pain management and vascular access; improvement of patient outcomes through implementation of evidence-based practice; and leadership in the development of comprehensive clinical practice standards, programs, and services. In 2020, Jennie Ong and Ruth published “Recommendations for Management of Noncytotoxic Vesicant Extravasations,” providing an updated list of noncytotoxic vesicants with recommended antidote and compress therapy. She remains active on the local and national levels of the Oncology Nursing Society and continues to peer review and publish.
Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN
Lisa Gorski has worked for over 35 years as a clinical nurse specialist (CNS)/educator for Wheaton Franciscan Home Health and Hospice, now Ascension at Home. Lisa is the author of more than 70 book chapters and journal articles and is the author of several books. She has served as the INS president from 2007-2008 and as the chair of the INS Standards of Practice Committee from 2009 to 2021, and is the cochair for the 2024 Standards. She is also the leader of the INS Vesicant Task Force. She speaks nationally and internationally on standards development, home health care, and infusion therapy/vascular access.
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel is a clinical nurse specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Barb has presented nationally on infusion-related topics, is a coauthor of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, is the chair of the INS Standard of Practice Committee for the 2024, 9th edition of the Standards, and has authored several publications on infusion therapy in the critical care setting. She also serves as faculty in a Bachelor of Science in Nursing (BSN) program, in areas of critical care and chronic illness.
-
Contains 3 Component(s), Includes Credits
Vesicant administration—and thus the risk of extravasation—occurs in most health care settings. Prevention and optimal management of extravasation injuries requires effective interprofessional collaboration and processes. This presentation will review one corporation’s journey to improve extravasation prevention, management. and outcome identification strategies through standardization of policy/procedure and vesicant list, optimizations of electronic documentation and incident reporting, and staff competency development in extravasation risk reduction and management.
Vesicant administration—and thus the risk of extravasation—occurs in most health care settings. Prevention and optimal management of extravasation injuries requires effective interprofessional collaboration and processes. This presentation will review one corporation’s journey to improve extravasation prevention, management. and outcome identification strategies through standardization of policy/procedure and vesicant list, optimizations of electronic documentation and incident reporting, and staff competency development in extravasation risk reduction and management.
Learning Objectives: At the conclusion of this session, learners will be able to:
· Identify evidence-based strategies to improve extravasation prevention and management.
· Describe benefits of interprofessional collaboration in extravasation care.
· Identify strategies to develop extravasation related competencies.
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel is a clinical nurse specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Barb has presented nationally on infusion-related topics, is a coauthor of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, is the chair of the INS Standard of Practice Committee for the 2024, 9th edition of the Standards, and has authored several publications on infusion therapy in the critical care setting. She also serves as faculty in a Bachelor of Science in Nursing (BSN) program, in areas of critical care and chronic illness.
-
Contains 3 Component(s), Includes Credits
Extravasation may result in severe patient injuries including scarring, permanent functional impairment, lifelong or chronic pain syndromes, and even loss of limb. Extravasation injuries require treatment, hospitalizations may be prolonged, or patients may be readmitted due to the need for further interventions. Extravasations may also result in allegations of malpractice. In this session, actual malpractice cases will be described focusing on breaches in the standard of care and exploring how infusion nurses can promote best, evidence-based practice in extravasation prevention.
Extravasation may result in severe patient injuries including scarring, permanent functional impairment, lifelong or chronic pain syndromes, and even loss of limb. Extravasation injuries require treatment, hospitalizations may be prolonged, or patients may be readmitted due to the need for further interventions. Extravasations may also result in allegations of malpractice. In this session, actual malpractice cases will be described focusing on breaches in the standard of care and exploring how infusion nurses can promote best, evidence-based practice in extravasation prevention.
Learning Objectives: At the conclusion of this session, learners will be able to:
1. Define malpractice.
2. Analyze failures in care that led to extravasations and actual lawsuits.
3. Discuss the infusion nurse role in promoting best practices for extravasation prevention.
Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN
Lisa Gorski has worked for over 35 years as a clinical nurse specialist (CNS)/educator for Wheaton Franciscan Home Health and Hospice, now Ascension at Home. Lisa is the author of more than 70 book chapters and journal articles and is the author of several books. She has served as the INS president from 2007-2008 and as the chair of the INS Standards of Practice Committee from 2009 to 2021, and is the cochair for the 2024 Standards. She is also the leader of the INS Vesicant Task Force. She speaks nationally and internationally on standards development, home health care, and infusion therapy/vascular access.
-
Contains 3 Component(s), Includes Credits
Identification and implementation of prevention practices are key to reducing the risk of extravasation and potential consequences. Prevention begins with assessment of each patient’s risk factors and the related risks associated with vascular access devices (VADs) and continues with safe administration practices. This session provides an overview of key assessments and safe vesicant administration practices.
Identification and implementation of prevention practices are key to reducing the risk of extravasation and potential consequences. Prevention begins with assessment of each patient’s risk factors and the related risks associated with vascular access devices (VADs) and continues with safe administration practices. This session provides an overview of key assessments and safe vesicant administration practices.
Learning Objectives: At the conclusion of this session, learners will be able to:
1. Review known patient and vascular access device–related risk factors.
2. Describe safe vesicant administration practices.
3. Recognize early evidence of extravasation.
Ruth Van Gerpen, MS, RN, APRN-CNS, AOCNS, PGMT-BC
Ruth Van Gerpen, MS, RN, APRN-CNS, AOCNS, PGMT-BC, is a clinical nurse specialist for oncology in Lincoln, Nebraska. An RN for 45 years, she has over 37 years of experience in oncology with subspecialties in pain management and vascular access. She retired in January 2022. Ruth has been responsible for education related to cancer; pain management and vascular access; improvement of patient outcomes through implementation of evidence-based practice; and leadership in the development of comprehensive clinical practice standards, programs, and services. In 2020, Jennie Ong and Ruth published “Recommendations for Management of Noncytotoxic Vesicant Extravasations,” providing an updated list of noncytotoxic vesicants with recommended antidote and compress therapy. She remains active on the local and national levels of the Oncology Nursing Society and continues to peer review and publish.
-
Contains 3 Component(s), Includes Credits
Optimal vascular access device (VAD) planning and site selection are critical aspects of extravasation risk reduction. The push to reduce central vascular access device (CVAD) utilization rates and related serious complications has resulted in an increased use of peripheral administration of medications that have historically been reserved for CVADs. Unfortunately, this shift increases extravasation risk due to the limitations of peripheral VADs. It is critical that the clinician tailor VAD planning and site selection to the specific patient and infusate risks in a given clinical setting. This presentation will compare and contrast extravasation risks with central versus peripheral delivery, describe risk reduction strategies in peripheral VAD placement and management, and explore the risks specific to the midline peripheral catheter.
Optimal vascular access device (VAD) planning and site selection are critical aspects of extravasation risk reduction. The push to reduce central vascular access device (CVAD) utilization rates and related serious complications has resulted in an increased use of peripheral administration of medications that have historically been reserved for CVADs. Unfortunately, this shift increases extravasation risk due to the limitations of peripheral VADs. It is critical that the clinician tailor VAD planning and site selection to the specific patient and infusate risks in a given clinical setting. This presentation will compare and contrast extravasation risks with central versus peripheral delivery, describe risk reduction strategies in peripheral VAD placement and management, and explore the risks specific to the midline peripheral catheter.
Learning Objectives: At the conclusion of this session, learners will be able to:
· Describe characteristics of peripherally compatible solutions.
· Discuss strategies to reduce extravasation risk with central versus peripheral VADs.
· Discuss extravasation risk reduction with the midline peripheral catheter.
Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel is a clinical nurse specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Barb has presented nationally on infusion-related topics, is a coauthor of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, is the chair of the INS Standard of Practice Committee for the 2024, 9th edition of the Standards, and has authored several publications on infusion therapy in the critical care setting. She also serves as faculty in a Bachelor of Science in Nursing (BSN) program, in areas of critical care and chronic illness.
-
Contains 3 Component(s), Includes Credits
Extravasation injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. In a follow-up to the 2017 Vesicant Task Force development of an evidence-based vesicant list, a new task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the Extravasation Prevention Checklist. This session provides an overview of the risks of extravasation and presents the updated vesicant list.
Extravasation injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. In a follow-up to the 2017 Vesicant Task Force development of an evidence-based vesicant list, a new task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the Extravasation Prevention Checklist. This session provides an overview of the risks of extravasation and presents the updated vesicant list.
Learning Objectives: At the conclusion of this session, learners will be able to:
1. Discuss the risks and consequences of extravasations.
2. Identify vesicant medications and solutions.
3. Differentiate between the categories of high, moderate, and cautionary vesicants.
Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN
Lisa Gorski has worked for over 35 years as a clinical nurse specialist (CNS)/educator for Wheaton Franciscan Home Health and Hospice, now Ascension at Home. Lisa is the author of more than 70 book chapters and journal articles and is the author of several books. She has served as the INS president from 2007-2008 and as the chair of the INS Standards of Practice Committee from 2009 to 2021, and is the cochair for the 2024 Standards. She is also the leader of the INS Vesicant Task Force. She speaks nationally and internationally on standards development, home health care, and infusion therapy/vascular access.